Key result
In patients with chronic heart failure, a red cell distribution width >14.45% independently predicted a nearly 4-fold increased risk of cardiovascular death or heart failure hospitalization at 1 year (OR 3.894).
Why the study?
The prognostic role of red cell distribution width compared with echocardiographic parameters in chronic heart failure patients was unclear.
Does red cell distribution width (RDW) predict cardiovascular death or heart failure hospitalization in patients with chronic heart failure?
Observational (n=232)
No
Does red cell distribution width (RDW) predict cardiovascular death or heart failure hospitalization in patients with chronic heart failure?
RDW is an independent predictor of adverse outcomes in chronic heart failure, providing prognostic information comparable to standard echocardiographic parameters.
Answers are grounded in this paper and cite their sources.
RDW independently predicted 1-year CV death/HF hospitalization in chronic HF; supports hypothesis-generating role as simple marker but leaves practice unchanged.
AIM: Red cell distribution width (RDW) is a measure of anisocytosis. Higher values are robustly associated to adverse outcome in several conditions, including chronic heart failure (HF). The present study aimed to compared its prognostic role with that of echocardiographic parameters in this kind of patients. METHODS: 32 stable and optimally treated chronic HF patients were enrolled. We excluded subjects suffering from valvular diseases or atrial fibrillation. They underwent blood sampling and echocardiographic examination. The primary endpoint of the study was cardiovascular death and/or HF hospitalization in the first year after enrolment. RESULTS: 49 patients reached the primary endpoint. RDW best cut-off at ROC curve was 14.45%. Univariate analysis associated mitral regurgitation grade, left ventricular ejection fraction (LVEF), posterior wall thickness (PWT), LV mass index, and RDW>14.45% to the primary endpoint. Multivariate regression analysis showed that LVEF, PWT, and RDW>14.45% predict the primary endpoint. Area under ROC curve was 0.808 for LVEF, 0.762 for NYHA class, and 0.761 for RDW. CONCLUSION: In chronic HF patients RDW is a better predictor of adverse outcome than several echocardiographic parameters associated to outcome itself (LV mass index, mitral regurgitation grade), predicts prognosis even adjusting for those parameters, age and NYHA class, and is associated to several echocardiographic measurements. In conclusion, RDW can expand our tool bag in order to better follow-up these patients.
No takes yet. Share an insight, caveat, or question.
Vizzardi et al. (2016) conducted an observational in Chronic heart failure (n=232). Red cell distribution width (RDW) > 14.45% vs. RDW ≤ 14.45% was evaluated on Cardiovascular death and/or HF hospitalization in the first year after enrolment (OR 3.894, 95% CI 1.042-14.555, p=0.043). In patients with chronic heart failure, a red cell distribution width >14.45% independently predicted a nearly 4-fold increased risk of cardiovascular death or heart failure hospitalization at 1 year (OR 3.894).
Synapse has enriched 10 related papers. Consider them for comparative context: